Talis Biomedical Corporation TLIS
2.84 USD +2.84
Day range unavailable
52-week range unavailable
- YTD
- 0.00%
- 1 year
- +71.08%
TLIS revenue history
Revenue is income from the company’s ordinary business activities.
2,134,000 USD
FY 2023 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | 2,134,000 | -2,678,000 | -55.65% |
| FY 2022 | 2022-12-31 | 4,812,000 | -3,381,000 | -41.27% |
| FY 2021 | 2021-12-31 | 8,193,000 | -2,745,000 | -25.10% |
| FY 2020 | 2020-12-31 | 10,938,000 | 6,961,000 | 175.03% |
| FY 2019 | 2019-12-31 | 3,977,000 | 1,587,000 | 66.40% |
| FY 2018 | 2018-12-31 | 2,390,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:01:32.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.